A detailed history of Fulton Breakefield Broenniman LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 90,764 shares of ABBV stock, worth $16.3 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
90,764
Previous 94,494 3.95%
Holding current value
$16.3 Million
Previous $16.2 Million 10.59%
% of portfolio
1.27%
Previous 1.22%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$163.84 - $199.33 $611,123 - $743,500
-3,730 Reduced 3.95%
90,764 $17.9 Million
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $194,880 - $227,576
-1,259 Reduced 1.31%
94,494 $16.2 Million
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $199,775 - $227,625
-1,250 Reduced 1.29%
95,753 $17.4 Million
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $74,441 - $83,838
-541 Reduced 0.55%
97,003 $15 Million
Q3 2023

Oct 20, 2023

BUY
$133.59 - $154.65 $78,283 - $90,624
586 Added 0.6%
97,544 $14.5 Million
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $305,833 - $380,589
2,308 Added 2.44%
96,958 $13.1 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $168,904 - $194,518
1,168 Added 1.25%
94,650 $15.1 Million
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $300,685 - $360,601
2,174 Added 2.38%
93,482 $15.1 Million
Q3 2022

Oct 17, 2022

SELL
$134.21 - $153.93 $37,847 - $43,408
-282 Reduced 0.31%
91,308 $12.3 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $138,032 - $175,484
-1,003 Reduced 1.08%
91,590 $14 Million
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $2.35 Million - $2.91 Million
17,785 Added 23.77%
92,593 $15 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $71,333 - $90,257
-664 Reduced 0.88%
74,808 $10.1 Million
Q3 2021

Oct 25, 2021

BUY
$106.4 - $120.78 $11,597 - $13,165
109 Added 0.14%
75,472 $8.14 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $190,009 - $211,681
1,806 Added 2.46%
75,363 $8.49 Million
Q1 2021

Apr 09, 2021

BUY
$102.3 - $112.62 $1.23 Million - $1.35 Million
12,007 Added 19.51%
73,557 $7.96 Million
Q4 2020

Jan 14, 2021

BUY
$80.49 - $108.67 $4.62 Million - $6.24 Million
57,414 Added 1388.15%
61,550 $6.6 Million
Q2 2020

Jul 10, 2020

SELL
$73.37 - $98.18 $24,138 - $32,301
-329 Reduced 7.37%
4,136 $406,000
Q1 2020

Apr 10, 2020

SELL
$64.5 - $97.79 $42,763 - $64,834
-663 Reduced 12.93%
4,465 $340,000
Q4 2019

Jan 14, 2020

BUY
$72.13 - $90.25 $49,697 - $62,182
689 Added 15.52%
5,128 $454,000
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $279,568 - $336,121
4,439 New
4,439 $336,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fulton Breakefield Broenniman LLC Portfolio

Follow Fulton Breakefield Broenniman LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.